Meclizine HCL
NDC 54738-025, Meclizine HCl 25mg Chewable Tablets, tablet, chewable, from Richmond Pharmaceuticals, Inc..
- Product NDC
- 54738-025
- Status
- Listed
- Labeler
- Richmond Pharmaceuticals, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- part336
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54738-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MECLIZINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Antiemetic [EPC]; Emesis Suppression [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54738-025-01 | 54738002501 | 100 TABLET, CHEWABLE in 1 BOTTLE (54738-025-01) |
| 54738-025-03 | 54738002503 | 1000 TABLET, CHEWABLE in 1 BOTTLE (54738-025-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 54738-025 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54738-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54738-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.